Ferrlecit 12.5 mg/mL

Ferrlecit 12.5 mg/mL is an intravenous injection containing sodium ferric gluconate complex, used to treat iron deficiency anemia. This single-use vial is suitable for medical professionals to administer under controlled conditions.

Ferrlecit 12.5 mg/mL is primarily used to address iron deficiency anemia in patients who cannot tolerate or do not respond to oral iron supplements. This intravenous injection is often considered when oral iron therapy is ineffective or impractical. The medication works by replenishing iron stores in the body, which is essential for the production of red blood cells.

Common effects of Ferrlecit 12.5 mg/mL may include temporary discomfort at the injection site, such as redness or swelling. Some patients might experience flu-like symptoms, including fever, chills, or muscle aches. These effects are generally mild and transient, but any persistent or severe reactions should be reported to a healthcare provider.

Ferrlecit 12.5 mg/mL should be administered by a healthcare professional in a clinical setting. Patients with a history of allergic reactions to iron products or any components of the injection should avoid this medication. It is important to monitor for signs of allergic reactions during and after administration.

Ferrlecit 12.5 mg/mL may interact with other medications, particularly those that affect iron metabolism or kidney function. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it may exacerbate certain side effects.